Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Twist Bioscience Corp (TWST)

Twist Bioscience Corp (TWST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,537,356
  • Shares Outstanding, K 61,274
  • Annual Sales, $ 376,570 K
  • Annual Income, $ -77,670 K
  • EBIT $ -136 M
  • EBITDA $ -111 M
  • 60-Month Beta 2.19
  • Price/Sales 6.72
  • Price/Cash Flow N/A
  • Price/Book 5.27

Options Overview Details

View History
  • Implied Volatility 79.86% (+0.95%)
  • Historical Volatility 53.76%
  • IV Percentile 47%
  • IV Rank 37.26%
  • IV High 117.20% on 11/20/25
  • IV Low 57.69% on 08/12/25
  • Expected Move (DTE 32) 2.38 (5.75%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 908
  • Volume Avg (30-Day) 264
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 4,593
  • Open Int (30-Day) 4,034
  • Expected Range 39.03 to 43.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.49
  • Number of Estimates 2
  • High Estimate -0.47
  • Low Estimate -0.50
  • Prior Year -0.53
  • Growth Rate Est. (year over year) +7.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.61 +35.28%
on 12/17/25
42.60 -2.79%
on 01/16/26
+10.28 (+33.02%)
since 12/16/25
3-Month
23.30 +77.73%
on 11/14/25
42.60 -2.79%
on 01/16/26
+10.66 (+34.67%)
since 10/16/25
52-Week
23.30 +77.73%
on 11/14/25
55.33 -25.16%
on 01/24/25
-4.46 (-9.72%)
since 01/16/25

Most Recent Stories

More News
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced preliminary, unaudited revenue for the first quarter of fiscal 2026 ended December 31, 2025. ...

TWST : 41.41 (+0.34%)
Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the J.P....

TWST : 41.41 (+0.34%)
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

TWST : 41.41 (+0.34%)
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research

Offering includes Animal Origin-Free Preps, Transfection-Grade Preps and Target Yield with turnaround time starting at four business days for Express Genes Enables nucleic acids therapeutics research,...

TWST : 41.41 (+0.34%)
Twist Bioscience: Fiscal Q4 Earnings Snapshot

Twist Bioscience: Fiscal Q4 Earnings Snapshot

TWST : 41.41 (+0.34%)
Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the fourth quarter and full year fiscal 2025...

TWST : 41.41 (+0.34%)
Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist,...

TWST : 41.41 (+0.34%)
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that it...

TWST : 41.41 (+0.34%)
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

TWST : 41.41 (+0.34%)
Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025

Company to host conference call at 8:00 AM ET

TWST : 41.41 (+0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered...

See More

Key Turning Points

3rd Resistance Point 45.01
2nd Resistance Point 43.80
1st Resistance Point 42.61
Last Price 41.41
1st Support Level 40.21
2nd Support Level 39.00
3rd Support Level 37.81

See More

52-Week High 55.33
Fibonacci 61.8% 43.10
Last Price 41.41
Fibonacci 50% 39.32
Fibonacci 38.2% 35.54
52-Week Low 23.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar